Taho Pharmaceuticals Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2017	FY 2016	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	2016 - 2020
Operating Revenue	7.78	-	1.07	6.36	12.4	36.01	Upgrade
Revenue	7.78	-	1.07	6.36	12.4	36.01	Upgrade
Revenue Growth (YoY)	-	-	-83.23%	-48.73%	-65.56%	2.68%	Upgrade
Cost of Revenue	2.9	-	1.14	1.3	13.54	22.36	Upgrade
Gross Profit	4.88	-	-0.07	5.06	-1.14	13.65	Upgrade
Selling, General & Admin	25.49	23.97	17.36	15.17	34.85	58.12	Upgrade
Research & Development	150.87	146.16	106.44	55.21	71.27	64.33	Upgrade
Operating Expenses	176.37	170.13	121.03	71.76	106.12	122.45	Upgrade
Operating Income	-171.49	-170.13	-121.1	-66.71	-107.25	-108.8	Upgrade
Interest Expense	-0.63	-0.9	-1.39	-0.53	-0.03	-0	Upgrade
Interest & Investment Income	5.06	3.02	1.3	0.52	0.63	0.31	Upgrade
Currency Exchange Gain (Loss)	0.34	0.34	0.27	-	-6.55	-2.15	Upgrade
Other Non Operating Income (Expenses)	0.76	0.24	0.24	0.43	-18.16	1.46	Upgrade
EBT Excluding Unusual Items	-165.97	-167.44	-120.68	-66.3	-131.36	-109.19	Upgrade
Gain (Loss) on Sale of Assets	-	-	-	-	-5.78	-	Upgrade
Pretax Income	-165.97	-167.44	-120.68	-66.3	-137.14	-109.19	Upgrade
Net Income	-165.97	-167.44	-120.68	-66.3	-137.14	-109.19	Upgrade
Net Income to Common	-165.97	-167.44	-120.68	-66.3	-137.14	-109.19	Upgrade
Shares Outstanding (Basic)	49	45	39	36	52	52	Upgrade
Shares Outstanding (Diluted)	49	45	39	36	52	52	Upgrade
Shares Change (YoY)	17.56%	17.18%	7.73%	-31.26%	-	-	Upgrade
EPS (Basic)	-3.37	-3.69	-3.12	-1.84	-2.62	-2.09	Upgrade
EPS (Diluted)	-3.37	-3.69	-3.12	-1.84	-2.62	-2.09	Upgrade
Free Cash Flow	-171.97	-165.73	-107.1	-63.61	-138.44	-103.23	Upgrade
Free Cash Flow Per Share	-3.49	-3.65	-2.76	-1.77	-2.65	-1.97	Upgrade
Gross Margin	62.67%	-	-6.75%	79.52%	-9.16%	37.90%	Upgrade
Operating Margin	-2204.54%	-	-11359.94%	-1049.20%	-864.87%	-302.11%	Upgrade
Profit Margin	-2133.50%	-	-11321.11%	-1042.75%	-1105.89%	-303.19%	Upgrade
Free Cash Flow Margin	-2210.67%	-	-10047.00%	-1000.49%	-1116.35%	-286.63%	Upgrade
EBITDA	-168.68	-168.32	-118.54	-57.77	-91.5	-92.86	Upgrade
EBITDA Margin	-	-	-	-	-	-257.84%	Upgrade
D&A For EBITDA	2.81	1.81	2.56	8.94	15.76	15.94	Upgrade
EBIT	-171.49	-170.13	-121.1	-66.71	-107.25	-108.8	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.